MedTrace Logo

Transcranial Magnetic Stimulation in Episodic Migraine (Magnet-EM)

NCT03556722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2022-11-02

No results posted yet for this study

Summary

This study will assess the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) as new preventive treatment of migraine.

Conditions

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation.

High frequency rTMS on left dorsolateral prefrontal cortex.

DEVICE

Sham rTMS

Sham rTMS without active magnetic coil on left dorsolateral prefrontal cortex.

Sponsors & Collaborators

  • Universiti Putra Malaysia

    lead OTHER

Principal Investigators

  • Hamidon B. Basri · University Putra Malaysia

  • Wan Aliaa B. Wan Sulaiman, MRCP · Universiti Putra Malaysia

  • Wan Aliaa B. Wan Sulaiman, MRCP · Universiti Putra Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2021-02-04
Completion
2022-04-01

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556722 on ClinicalTrials.gov